It was shown that in patients with regionally metastatic differentiated thyroid cancer, PD-1 + Tim-3 + CD8 + T cells are variably deficient in their ability to produce IL2, TNFα, and IFNγ [70]. The gene discussed is HAVCR2; the disease is thyroid cancer.